Growth and Tolerance of Infants Fed Formula for 16 Weeks

Growth and Tolerance Trial of Iron-fortified infant formulas

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Child Development

Age range

1 day–14 day

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Visions Clinical Research-Tucson, Tucson, Arizona, United States

About this study

16 WEEK GROWTH AND TOLERANCE

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Healthy term infants, 37-42 weeks gestational age

Exclusion criteria

Any condition that would negatively impact assessment of growth and tolerance

Treatment and study plan

Infant Formula

Other

Multi-centered, prospective, randomized clinical trial

Primary outcomes

Growth

Time frame: 16 weeks

Weight Gain

Sponsors and collaborators

Lead sponsor

Nature's One

Industry

Registry information

Official study title

Growth Monitoring Study of Infants Fed Formula for 16 Weeks

Important dates

Study start: 2018
Primary completion: 2020
Study completion: 2020
First posted: Apr 3, 2018
Registry last updated: Jul 10, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed